Xist ribonucleoproteins promote female sex-biased autoimmunity
Cell · 2024-02 · 187 (3) · 733-749.e16
DOI: 10.1016/j.cell.2023.12.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-02. Verfasst von Diana R Dou und 23 weiteren Autor:innen. Beteiligte Einrichtung: Center for Personal Dynamic Regulomes, Program in Epithelial Biology, Department of Dermatology, Stanford University School of Medicine, Stanford, CA…. Hauptthemen laut MEDLINE: Autoantibodies, Autoimmune Diseases, RNA, Long Noncoding. Die Arbeit wurde bisher 245-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Autoimmune diseases disproportionately affect females more than males. The XX sex chromosome complement is strongly associated with susceptibility to autoimmunity. Xist long non-coding RNA (lncRNA) is expressed only in females to randomly inactivate one of the two X chromosomes to achieve gene dosage compensation. Here, we show that the Xist ribonucleoprotein (RNP) complex comprising numerous autoantigenic components is an important driver of sex-biased autoimmunity. Inducible transgenic expression of a non-silencing form of Xist in male mice introduced Xist RNP complexes and sufficed to produce autoantibodies. Male SJL/J mice expressing transgenic Xist developed more severe multi-organ pathology in a pristane-induced lupus model than wild-type males. Xist expression in males reprogrammed T and B cell populations and chromatin states to more resemble wild-type females. Human patients with autoimmune diseases displayed significant autoantibodies to multiple components of XIST RNP. Thus, a sex-specific lncRNA scaffolds ubiquitous RNP components to drive sex-biased immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Personal Dynamic Regulomes, Program in Epithelial Biology, Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Comparative Medicine, Stanford University, Stanford, CA, USA.
- Autoimmunity and Serology Profiling, Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
- Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA.
Förderung
- NIAMS NIH HHS
- NIH
- Howard Hughes Medical Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Scleroderma Research Foundation
- Kao Corporation
Zitieren
APA
Dou, D. R., Zhao, Y., Belk, J. A., Zhao, Y., Casey, K. M., Chen, D. C., Li, R., Yu, B., Srinivasan, S., Abe, B. T., Kraft, K., Hellström, C., Sjöberg, R., Chang, S., Feng, A., Goldman, D. W., Shah, A. A., Petri, M., Chung, L. S., …, & Chang, H. Y. (2024). Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell, 187(3), 733-749.e16. https://doi.org/10.1016/j.cell.2023.12.037
Vancouver
Dou DR, Zhao Y, Belk JA, Zhao Y, Casey KM, Chen DC, et al. Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell. 2024;187(3):733-749.e16. doi:10.1016/j.cell.2023.12.037
BibTeX
@article{Dou2024,
author = {Dou, Diana R and Zhao, Yanding and Belk, Julia A and Zhao, Yang and Casey, Kerriann M and Chen, Derek C and Li, Rui and Yu, Bingfei and Srinivasan, Suhas and Abe, Brian T and Kraft, Katerina and Hellström, Ceke and Sjöberg, Ronald and Chang, Sarah and Feng, Allan and Goldman, Daniel W and Shah, Ami A and Petri, Michelle and Chung, Lorinda S and Fiorentino, David F and Lundberg, Emma K and Wutz, Anton and Utz, Paul J and Chang, Howard Y},
title = {Xist ribonucleoproteins promote female sex-biased autoimmunity},
journal = {Cell},
year = {2024},
volume = {187},
number = {3},
pages = {733--749.e16},
doi = {10.1016/j.cell.2023.12.037}
}
EUVIMED